Summary financial information for affiliated companies accounted for by the equity method for the periods presented, compiled from the equity investee's financial statements and reported on a one quarter lag is as follows:

From 2019 through December 31, 2025, the Company invested $8,500,000 for 11,236,111 shares in SSOF resulting in equity ownership of 16.99% as of December 31, 2025. The December 31, 2025 carrying value of the Company's investment in SSOF reflects an observable transaction adjustment recorded by the Company in 2023. On October 1, 2025, the Company began accounting for the investment in SSOF using the equity method. For the three and six-months ended June 30, 2026, the Company recognized $12,716 and $240,560, respectively, in equity loss from affiliates for our investment in SSOF.

At December 31, 2025, the Company had an advance to SSOF of $9,400,000. During the three-months ended March 31, 2026, the Company advanced an additional $5,750,000. On March 26, 2026, all advances, totaling $15,150,000 were converted into 23,307,692 shares of SSOF common stock at $0.65 per share. On April 30, 2026, the Company converted accrued interest from advances of $237,415 to 365,255 additional shares of SSOF common stock at $0.65 per share (see Note 4). As of June 30, 2026, the Company subscribed to and invested an additional $13,640,000 for 20,984,615 additional shares of SSOF common stock at $0.65 per share. At June 30, 2026 and December 31, 2025, the Company owns 55,893,673 and 11,236,111, respectively, in SSOF shares of common stock, representing an ownership of 47.63% and 16.99%, respectively.

In connection with the increase in percentage ownership, management reassessed its prior conclusions regarding the Company's variable interest in SSOF and its primary beneficiaries. The Company concluded that SSOF continues to be a variable interest entity in which it holds a variable interest and that it is not the primary beneficiary of SSOF since the Company does not have the power, individually or together with its related parties, to direct the activities of SSOF that most significantly affect SSOF's economic performance. Although the Company's chief executive officer also serves as an executive of SSOF, this relationship was previously evaluated and was a factor in the prior conclusion, which remains unchanged. Accordingly, SSOF is not consolidated, and the Company accounts for its investment in SSOF under the equity method. At June 30, 2026, the Company's maximum loss exposure from of its involvement in SSOF is limited to its investment of $49,011,855.

On March 1, 2024, the Company entered into a Securities Purchase Agreement (the “Developer Securities Purchase Agreement”) with Magnesis and recognized an initial investment of $1,290,614. Concurrently and in connection with entering into the Developer Securities Purchase Agreement, the Company and Magnesis entered into a Development Services Agreement (“DSA”) for purposes of conducting certain research and development work (see Note 9).

At June 30, 2026, the future remaining payments on the investment purchase, net implied interest, totaled $1,314,205 (see Note 7). For the three and six-months ended June 30, 2026, the Company recorded $24,000 and $48,000, respectively, in equity loss from affiliates for our investment in Magnesis. For the three and six-months ended June 30, 2025, the Company recognized $24,000 in equity loss from affiliates and $17,438 in equity gain from affiliates for our investment in Magnesis. During the six-months ended June 30, 2026 and 2025, the Company paid $0 to Magnesis. In the second quarter of 2026, we determined that our investment in Magnesis was fully impaired and as a result, the Company recorded an impairment of $1,031,371 for the net balance of the investment in our Bioleum (Fuels Segment). The total impairment in investment asset of $1,031,371 was recognized in our condensed consolidated statements of operations.

At June 30, 2026 and December 31, 2025, the Company owned 35,662 Green Li-ion preferred shares. On April 18, 2026, Green Li-ion entered into a bridge financing agreement with various parties and issued warrants which decreased our ownership from 13.34% to 11.98%. The Company monitors additional equity issuances and other potential orderly transactions of Green Li-ion to assess whether the equity securities issued are similar investments requiring adjustments of our investment's carrying value to fair value. During the six-months ended June 30, 2026 and 2025, no adjustments were made to the carrying value of our investment in Green Li-ion as no orderly transactions for investments similar to the Company's investment were observed during those periods.